• Home
  • About
  • ‘Enforcement 40’ for 2020
  • Webcasts
  • Enforcement Hall of Fame
  • Contact
Securities Docket
FTI 480x60
  • Class Actions
  • Criminal
  • Global
  • People
  • SD Insider
  • SEC
  • Video
  • Subscribe by email
  • Subscribe
Browse: Home / 2009 / March / 11 / Enforcement Action, Oncology Edition (cont.)

Enforcement Action, Oncology Edition (cont.)

By Securities Docket on March 11, 2009, 10:55 pm

Back in September 2008, two cases in a span of two days prompted me to ask (in “Enforcement Action, Oncology Edition“) “which is worse — inducing shareholders to purchase $6.5 million of your company’s stock by falsely depicting the company as being on the verge of success curing cancer?  Or defrauding a federal judge by falsely depicting yourself as having cancer such that you are so ill that you cannot participate in a potential SEC case against you?”

Well, the key player in the latter half of that question has now come clean.  Get all the details in this post on my Enforcement Action blog over at Compliance Week.

Blog Widget by LinkWithin

Posted in Criminal | Tagged Obstruction

« Previous Next »

Subscribe

‘Enforcement 40’ for 2020

Securities-Docket_Medium-Rectangle_CaseStudyArrow

Our Sponsors

Securities-Docket_260x125_14Sec Ankura 260x125

Join Us On LinkedIn

Join the Securities Litigation and Enforcement Group on LinkedIn

Archives

Copyright © 2022 Securities Docket.

Powered by WordPress and Hybrid.